bharat biotech
- Bangalore
Bharat Biotech evinces interest to invest in Karnataka
Bengaluru: Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka. Ella, Chairman and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries…
- Hyderabad
Intranasal vaccine will be global game changer: Krishna Ella
Hyderabad: Bharat Biotech’s iNCOVACC, the world’s first intranasal vaccine for Covid-19 which received approval for emergency use in India on Tuesday, will be a global game changer in intranasal vaccines technology and…
- India
India’s first intranasal vaccine for COVID-19 gets DCGI approval
New Delhi: India’s first intranasal COVID-19 vaccine by Bharat Biotech on Tuesday got approval from the Drug Controller General of India for the 18+ age group for restricted use in emergency situations.…
- Hyderabad
Nigeria introduces Hyderabad’s Bharat Biotech’s vaccine for children
Hyderabad: Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, announced its rotavirus oral vaccine ROTAVAC® has been introduced by Nigeria to immunize its…
- Health
Bharat Biotech’s intranasal Covid vaccine proven safe in clinical trials
Hyderabad: Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. The Hyderabad-based company completed…
- Hyderabad
Bharat Biotech expects nod for intranasal COVID-19 vaccine in Aug
Hyderabad: Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of the company, Krishna Ella…
- Hyderabad
Bharat Biotech chief exhorts students to be innovative, entrepreneurial
Hyderabad: Bharat Biotech chairman and managing director Krishna Ella on Saturday exhorted students to be innovative and entrepreneurial to create jobs for the country even as he highlighted India’s traditional knowledge. Ella,…
- Hyderabad
Covaxin booster dose gives long-term immunity against COVID: Bharat Biotech
Hyderabad: Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against…
- Hyderabad
Covaxin safe for children aged 2-18 years: Bharat Biotech
Hyderabad: Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study,…
- India
Germany approves Bharat Biotech’s Covaxin
New Delhi: Germany on Thursday approved the ‘Made in India’ Bharat Biotech’s Covid vaccine Covaxin. “Covaxin has been approved by Germany. The entrants will no longer need proof of vaccination as the Federal…
- Top Stories
SII, Bharat Biotech cut prices of COVID-19 vaccines for pvt hospitals to Rs 225
New Delhi: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs…
- Hyderabad
No impact on efficacy, safety of Covaxin: Bharat Biotech after WHO suspension
Hyderabad: Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is “no impact on efficacy and safety of the COVID-19 vaccine COVAXIN” after the World Health Organisation suspended it from its…
- Hyderabad
Bharat Biotech temporarily slows down COVAXIN production
Hyderabad: Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.…
- Health
Bharat Biotech partners with Biofabri to develop TB vaccine
Hyderabad: Vaccine maker Bharat Biotech on Wednesday announced partnership with Spanish biopharmaceutical company Biofabri to develop, manufacture and market a new tuberculosis vaccine in more than 70 countries in Southeast Asia and…
- Hyderabad
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotech
Hyderabad: Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States. “Ocugen, Inc (NASDAQ: OCGN) announced that the…
